Biotech News
TherapeuticsMD Announces Full Year 2023 Financial Results
ir.therapeuticsmd.com2026-05-06 15:14 EST
• Evaluation of strategic alternatives continues BOCA RATON, Fla. --(BUSINESS WIRE)--Mar. 29, 2024-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31,